Drug Shortage Report for TEVA-TOBRAMYCIN
Report ID | 106942 |
Drug Identification Number | 02389622 |
Brand name | TEVA-TOBRAMYCIN |
Common or Proper name | TOBRAMYCIN INH SLN 60MG/ML |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | TOBRAMYCIN |
Strength(s) | 60MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION |
Packaging size | 56 |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-02-20 |
Estimated end date | 2020-03-31 |
Actual end date | 2020-03-25 |
Shortage status | Resolved |
Updated date | 2020-03-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-03-26 | French | Compare |
v3 | 2020-03-26 | English | Compare |
v2 | 2020-02-21 | French | Compare |
v1 | 2020-02-21 | English | Compare |
Showing 1 to 4 of 4